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A B S T R A C T  
Present study was aimed to evaluate the gastrokinetic and gastroprotective 
effect of Gasex a polyherbal formulation in experimental models of phenol red 
test meal method for gastrokinetic activity and acid-induced gastrointestinal 
lesions for gastroprotective activity. Gasex at a dose of 500 and 1000 mg/kg 
showed statistically significant gastrokinetic activity by increasing the 
percentage of gastric emptying and small intestinal transit, the higher dose of 
Gasex was comparable to the reference standard Domeperidone (10 mg/kg). 
The higher dose of Gasex (1000 mg/kg) showed gastroprotective activity by 
significantly decreasing the gastric volume and mean gastric lesion score and 
the same was reflected in histopathological findings. The present finding 
highlights few of the underlying modes of action of Gasex in the successful 
management of various gastrointestinal conditions. 
Keywords: Gasex, Phenol red, HCl, gastrokinetic , gastroprotective, 
histopathology. 
Introduction 
Indigestion or dyspepsia is a disorder characterized by 
upper abdominal pain or discomfort, with associated 
features that may include satiety, upper abdominal 
fullness, bloating, belching, nausea or heartburn in the 
absence of any proven structural abnormality. The 
treatment of dyspepsia is less systematic owing to the 
lack of its pathophyisiological markers. Gastroparesis, 
or delayed gastric emptying, is another medical 
condition consisting of a paresis (partial paralysis) of 
the stomach, resulting in food remaining in the 
stomach for a longer period of time than normal. It is 
one of the troublesome complications of long-term 
diabetes and also numbers of commonly prescribed 
drugs are known to decrease gastric emptying [1, 2]  
 
The common symptom of gastroparesis includes 
nausea, early satiety, heartburn, abdominal pain etc. In 
recent times, prokinetic drugs are used clinically in the 
management of dyspepsia and gastroparesis along 
with proton pump inhibitors, but however the outcomes 
of such a treatment is far from satisfactory due to 
availability factors, cost and associated adverse 
effects. Indigenous or complementary medicines are 
widely used in the management of dyspepsia but their 
scientific evaluation is lacking [3]  
 
Ayurveda, an Indian system of medicine has 
recommended number of drugs from plant sources for 
the management of indigestion and other gastric 
disorders [4]. Gasex, an Ayurvedic preparation of The 
Himalaya Drug Company has been used in the 
management of patients with dyspepsia and allied 
conditions for more than four decades. Gasex contains 
following indigenous herbal materials as a major 
ingredients: Aconitum palmatum, Piper nigrum, 
Embelia ribes, Triphala, Zingiber officinale, Cowrie 
bhasma, Shankh bhasma etc. The exact mode of 
action of Gasex is not evaluated, so the present study 
was aimed at evaluating its gastrokinetic and 
gastroprotective activity in experimental models.  
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Materials and Methods: 
Drugs and Chemicals:  Gasex (The Himalaya Drug 
Company, Bangalore), Domeperidone (Torrent 
Pharmaceuticals Ltd., Ahmedabad, India), Phenol red 
sodium (SD fine chemicals limited) were used and all 
the other chemicals used in the experiments were of 
analytical grade and purchased from reputed suppliers. 
 
Experimental Animals 
Inbred Wistar rats (250-300 g) were used and they 
were housed in standard conditions of temperature (22 
± 3˚C), relative humidity (55 ± 5%) and light (12 h 
light/dark cycle) before and during the study. They 
were fed with standard pellet diet and water ad libitum. 
All the experimental protocols were approved by the 
Institutional Animal Ethics Committee (IAEC) of The 
Himalaya Drug Company, Bangalore, and the animals 
received humane care as per the guidelines prescribed 
by Committee for the Purpose of Control and 
Supervision on Experiments on Animals (CPCSEA), 
The Ministry of Environment & Forests, Government of 
India. 
 
Experimental protocol 
Preparation of Phenol red test meal: 
25 mg of Phenol red indicator was weighed and 
dissolved in 50 ml of distilled water and filtered. The 
filtrate was heated to 70oC and it was mixed with 
methylcellulose (0.75g) with continuous stirring. The 
mixture was then cooled to 37oC. 
 
Gastrokinetic activity in rats administered with phenol 
red test meal: 
Thirty two adult male Wistar rats, weighing between 
250- 300 g were used for the study. The animals were 
segregated into 4 groups of 8 each. Group-I, served as 
Control and received DM water, while Group-II and III 
received Gasex granules 500 and 1000 mg/kg/p.o per 
day respectively for 7 days and Group-IV served as 
reference standard received single dose of 
domeperidone at 10 mg/kg/p.o. on day 8. After 7 days 
of treatment, all the animals were fasted for 18 hours 
prior to the experiment and water was provided ad 
libitum. On day 8, Two hours after the assigned 
treatment, phenol red meal (0.5 ml/animal) was orally 
administedred to all the animals.  Fifteen mins after the 
administration of phenol red meal, the animals were 
euthanized by cervical dislocation and the abdomen 
was opened and stomach was isolated by ligating the 
cardiac and pyloric ends. The stomach was cut in to 
pieces and homogenised with 25 ml of 0.1 N NaOH. 
To this 5ml of 0.5ml of trichloroacetic acid (20 % w/v) 
was added and centrifuged at 3000 rpms for 20 mins. 
To 1 ml of supernatant 4 ml of the 0.5N NaOH was 
added. The absorbance of resultant pink colour liquid 
was measured using Synergy Biotek HT 
spectrophotometer at 560nm wavelength. The 
percentage of gastric emptying was calculated by the 
formula:   
 Percentage Gastric Emptying = 1 − XY   X 100 
 
Where,  X is the amount of phenol red present in the 
stomach homogenate from test animal and Y is 
amount of phenol red recovered from control animal. 
 
Similarly, the intestine from duodenum to ileo-ceacal 
junction was dissected out and the distance travelled 
by phenol red and total length of the intestine (from 
duodenum to ileo-ceacal junction) was recorded. The 
small intestinal transit (SIT) was calculated by 
considering the total distance travelled by phenol red 
meal divided by total length of the small intestine 
multiplied by 100. [5,6,7] 
. 
 
Gastroprotective activity in pylorus ligated rats loaded 
with HCl:  
Thirty two adult male wistar rats, weighing between 
250-300 g were used for the study. The animals were 
segregated into 4 groups of 8 each. Group I and II, 
served as normal control and positive (pylorus ligated) 
control and received DM water 10 ml/kg/p.o., Group III 
and IV received Gasex granules 500 and 1000 
mg/kg/p.o. per day respectively for 7 days. On day-8 
overnight fasted animals were administered with 
assigned treatment,  one hour after the respective 
treatment all the animals were subjected to pylorus 
ligation; In brief, Pylorus ligation was carried out 
through a midline abdominal incision under ether 
anaesthesia and the animals were loaded with 10ml/kg 
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b.wt. of 0.25M HCl and they were euthanized 3 hours 
after HCl administration by ether overdose. After 
removing the stomach, the gastric volume and gastric 
lesion scores were recorded. The degree of gastric 
mucosal damage was assigned and scaled 0 to 4.  The 
score of 0 : no visible lesions; 1: a few erosions; 2: 
total lesion area≤30 mm2; 3: total lesion area ≥30 mm2; 
4 : perforation. After scoring, the gastric tissues were 
processed for histopathology. [8, 9] 
Statistical analysis: The results of study were 
expressed as mean ± SEM and analyzed statistically 
using One Way ANOVA followed by Dunett’s multiple 
comparison test to find out the level of significance. 
The minimum level of significance was fixed at 95% 
confidence limit. The analysis was performed using 
Graph pad Prism software package (Version 4.03). 
 
Results: 
 
Figure 1: Effect of Gasex on percentage of gastric emptying in rats administered with phenol red test meal. 
 
 
Figure 2: Effect of Gasex on percentage of small intestinal transit in rats administered with phenol red test meal. 
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Figure 3: Effect of Gasex on gastric volume in pylorus ligated rats loaded with HCl. 
 
 
Figure 4: Effect of Gasex on mean gastric lesion score in pylorus ligated rats loaded with HCl. 
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Figure 5. Section of rat stomach showing normal appearance (H&E x 400). 
 
 
Figure 6. Group II Untreated Positive Control: Section of stomach showing multifocal area of erosion/ulceration of 
mucosa with edema and leucocytic infiltration in lamina propria (H&E x 400).  
 Mukhram et al. International Journal of Phytomedicine 3 (2011) 557-566 
 
562 
 
 
Fig 7. Group III Animals Treated with Gasex 500mg/kg: Section of stomach showing minimal focal area of 
erosion/ulcer with surface epithelial damage ((H&E x 400).  
 
 
 
Fig 8. Group IV Animals Treated with Gasex 1000mg/kg: Section of the stomach showing near normal structure and 
architectural intactness (H&E x 400) 
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Results and Discussion: 
The present pre-clinical study was carried out to 
evaluate gastrokinetic and gastroprotective activity of 
Gasex granules in rats.  
 
Assessment of gastrokinetic activity using phenol red 
as an indicator:  
It was found that Gasex, at both the selected doses 
exhibited gastrokinetic effect in rats when tested by 
phenol red meal method. Fifteen minutes after the 
administration of phenol red meal, gastric emptying in 
normal rats was found to be 38.18 %, whereas in 
Gasex (500 and 1000 mg/kg/p.o.) treated groups 
showed significant increase (57.69 % and 62.81 %) in 
gastric emptying compared to control untreated group. 
Further, animals treated with single dose of 
Domperidone (10 mg/kg/p.o.) showed 65.78 % gastric 
emptying and which was found to be statistically 
significant compared to control group (Fig.1). 
 
Similarly, small intestinal transit (SIT) of normal control 
rats were found to be 48.74 %, whereas in Gasex at a 
dose of 500 & 1000 mg/kg/p.o (72.97% & 73.40%) and 
single dose of Domperidone at a dose of 10 mg/kg/po 
(76.92%) showed a significant increase in SIT 
percentage compared to control group (Fig.2).The 
effect observed in groups of animals treated with 
Gasex was comparable to that of those treated with 
standard prokinetic drug domperidone at selected 
dose, method employed and mode of administration. 
 
Gastroprotective activity in pylorus ligated rats: 
Gastric volume was measured in the pylorus ligated 
rats loaded with 10ml/kg/p.o. of 0.25M HCl. In 
untreated positive control group the gastric volume 
was 14.75ml and in the animals treated with Gasex at 
a dose of 500 and 1000 mg/kg/p.o. it was 12.50 and 
11.63ml respectively (Fig.3 & 4). Gasex at a dose of 
1000 mg/kg/p.o significantly decrease the gastric 
volume and mean gastric lesion score compared to 
untreated positive control. Histopathological evaluation 
also indicates, Gasex appreciably reversed the acid-
induced damage of gastric mucosa in pylorus ligated 
rats (Fig 5 to 8).The above observation indicates 
Gasex has gastroprotective activity against acid-
induced changes. 
Gastric motility disorders can be idiopathic or it can be 
due to postsurgical states like vagotomy or due to 
diseases like functional dyspepsia, type 1 diabetes, 
chronic renal failure, etc. [10],  gastric motility disorders 
are relatively common. In Finnish primary care 
patients, about 43% of all dyspepsia is functional 
[11].Patients with functional dyspepsia, 30% have 
delayed gastric emptying, 40% impaired gastric 
accommodation and 37% hypersensitivity to gastric 
distention[12]. Diabetic gastroparesis with delayed 
gastric emptying occurs in 30 to 50% of both type 1 
and type 2 diabetes at tertiary centers [13,14,15]. 
Delayed gastric emptying occurs in 36% of patients 
with chronic renal failure [16].Gastroparesis, functional 
dyspepsia, neuromuscular disorders of the stomach 
involving both motor and sensory dysfunctions are 
increasingly recognized as a cause of chronic 
abdominal symptoms in patients and thus represent 
significant health care burden [17]. 
 
Now a days, several prokinetic drugs like 
domeperidone, metoclopramide and cisapride are 
used for the treatment of diseases associated with 
delayed gastric emptying, like gastroparesis, bloating, 
abdominal discomfort, nausea, vomiting, functional 
dyspepsia etc.. However their use is limited by an 
array of side effects, which occur as a result of their 
widespread actions [4]. 
 
Gasex, a well known herbomineral ayurvedic 
formulation of ‘Himalaya Drug Company’ is used for 
various gastrointestinal disorders. Its use in 
hyperacidity and abdominal discomfort is known, it has 
been reported to have an effective and safe role in the 
gastrointestinal complaints such as functional 
dyspepsia, flatulence, eructation, acid regurgitation, 
uneasiness with abdominal distension, and epigastric 
pain etc. It is also widely used prior to radiological 
investigation of abdomen. [18, 19, 20] but the 
prokinetic property of this formulation has not been 
evaluated.  
 
In the present study, Domperidone a potent prokinetic 
drug has been taken as a reference standard. It is a 
peripheral dopamine2-receptor antagonist which 
regulates the motility of gastric and small intestinal 
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smooth muscle and has been shown to have some 
effects on the motor function of the esophagus. It acts 
as both an antiemetic and an upper gastrointestinal 
tract prokinetic agent [21]. It increases basal lower 
esophageal sphincter pressure, inhibit relaxation of the 
gastric fundus, enhance antral contractility and relax 
the pyloric sphincter and also stimulate and coordinate 
gastroduodenal motility [22,23]. Domperidone has 
been approved for the symptomatic management of 
upper gastrointestinal tract motility disorders 
associated with chronic and subacute gastritis and 
diabetic gastroparesis[24]. It may also be used to 
prevent gastrointestinal symptoms associated with the 
use of dopamine agonist agents in Parkinson's 
disease. Studies in animals and humans have shown 
the efficacy of the agent in promoting gastric emptying 
of several types of liquid and solid meals [25,26] 
 
Most of the herbs used in this formulation have been 
reported for its effect on gastrointestinal disorders. 
Aconitum palmatum is found to be effective in 
dyspepsia, stomach irritability and nausea. Cowrie, a 
naturally processed calcium carbonate, is used in 
dyspepsia, indigestion, sprue, duodenal and gastric 
ulcers, and hyperacidity. Shankha bhasma which is 
mainly a silicate of magnesia is derived from conch 
shell is used in the treatment of ulcers. The fruits of 
Piper nigrum contain piperine, which is reported to 
have antioxidant activity and may contribute to the 
prevention of gastric ulcerations. It is known to protect 
the stomach against ulceration by decreasing the 
volume of gastric juice, gastric acidity and pepsin. 
Embelia ribes has been found to be effective against 
helminthes and is also reported to have analgesic and 
antibacterial activities, which may help in preventing 
gastric ulcerations. Triphala, a homogenous mixture of 
three fruits— Emblica officinalis, Terminalia chebula 
and Terminalia bellerica is a rich source of vitamin C, 
ellagic acid, gallic acid, and chebulinic acid, the 
phenolic compounds present in these extracts are 
mostly responsible for their free radical scavenging 
activity and may be helpful in various gastric problems. 
Zingiber officinale, used to treat various 
gastrointestinal tract disorders and is known to 
possess anti-emetic, stomachic and carminative 
properties [27]. The gastrokinetic and gastroprotective 
effect of Gasex granules may be due to the synergistic 
effect of the various herbs used in this formulation. 
 
Conclusion: 
The results of the present set of experiments indicates 
Gasex has gastrokinetic activity when tested by  
phenol red test meal method and it also has a 
gastroprotective activity against acid-induced gastro 
intestinal changes, which may highlight, few of the 
underlying mode of action of Gasex in the successful 
management of various gastrointestinal conditions. 
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